Articles
| Open Access |
DOI: EMERGENT CMV SEROCONVERSION WITH HIGH AVIDITY IN A PRIMIPAROUS WOMAN DURING EARLY PREGNANCY: A CASE STUDY
Marie-Michel Auger , Clinical Pathologist, Hospital Erasme, BelgiumAbstract
This case study presents a rare instance of cytomegalovirus (CMV) seroconversion in a primiparous woman during her first trimester of pregnancy, accompanied by a significant increase in CMV-specific antibody avidity. The emergence of CMV seropositivity in pregnancy raises concerns due to potential vertical transmission risks. However, the intriguing aspect of this case lies in the unusually high avidity of the CMV-specific antibodies developed post-seroconversion. This phenomenon suggests a previous immune priming event or cross-reactive responses. The case underscores the complexity of CMV infections during pregnancy and the need for careful monitoring and research to comprehend the implications of heightened antibody avidity in the context of maternal-fetal health.
Keywords
CMV seroconversion, avidity, pregnancy
References
Bodéus M, Feyder S, Goubau P (1998) Avidity of IgG antibodies distinghishes primary from non-primary cytomegalovirus infection in pregnant women. Clin Diagn Virol 9(1): 9-16.
Lazzarotto T, Spezzacatena P, Pradelli P, Abate DA, Varani S et al. (1997) Avidity of Immunoglobulins G Directed Against Human Cytomegalovirus During Primary and Secondary Infections in Immunocompetent and Immunocompromised Subjects, Clin Diagn Lab Immunol 4(4): 469-473.
Sellier Y, Guilleminot T, Ville Y, Leruez-Ville M (2015) Comparison of The Liaison® CMV IgG Avidity II and the Vidas® CMV IgG Avidity II assays for the diagnosis of primary infection in pregnant wome. J Clin Virol 72: 46-48.
Naing ZW, Scott GM, Shand A, Hamilton ST, van Zuylen WJ, et al. (2015) Congenital cytomegalovirus infection in pregnancy: a review of prevalence, clinical features, diagnosis and prevention, Aust N Z J Obstet Gynaeco 56(1): 9-18.
Revello MG, Genini E, Gorini G, Klersy C, Piralla A, et al. (2010) Comparative evaluation of eight commercial human cytomegalovirus avidity assays. J Clin Virol 48(4): 255-259.
Berth M, Grangeot-Keros L, Heskia F, Dugua JM, Vauloup-Fellous C (2014) Analytical issues possibly affecting the performance of commercial human cytomegalovirus IgG avidity assays. Eur J Clin Microbiol Infect Dis 33(9): 1574-1584.
Article Statistics
Copyright License
Copyright (c) 2023 Marie-Michel Auger
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.